TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of subjects that completed all 5 WET sessions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of reported adverse events reported
Endpoint domain: Adverse events/effects
Primary endpoint: Bleeding Episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain experiences
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Daily Activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Numerical Rating Scale-101 Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Modified Ober's test using digital inclinometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Noble's Compression test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ITB Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Daily Exercise Diary
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Digital sphygmomanometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: NDI (U) (Neck Disability Index)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Tumour recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Transcranial magnetic stimulation-evoked potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cosmesis assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Absorption of HMOs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excretion of HMOs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial emotion recognition test (TREF test)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Average facial temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safe dose of PRG-1801 infusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of AE after PRG-1801 infusion
Endpoint domain: Adverse events/effects
Primary endpoint: acceleration of canine retraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90-day excellent clinical outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of 3% hypertonic saline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Adverse event and serious adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Serum Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Maximum Serum Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve to the last measurable time point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve extrapolated to infinity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Influenza-specific antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Diagnostic accuracy of multisteroid panel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Postoperative monosyllabic word recognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality due to anaphylactic shock
Endpoint domain: Mortality/survival
Primary endpoint: Knee Society Score (KSS) Function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in tcNA dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in tcDNA dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biofilm eradication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Word Recognition Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multi-word Recognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CCS Class of Worsening angina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with target vessel Myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Ischemia-driven Target lesion revascularization (TLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Multi-Organ Blood Perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bladder and bowel dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days of feed intolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Overall Depression Severity and Impairment Scale (ODSIS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: World Health Organization Well-Being Index-5 (WHO-5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cervicogenic dizziness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The risk of falling
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The fear of falling
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean Percent Reduction of 8-oxo-dG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean Percent Reduction of common deletion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Diagnosis of spontaneous myocardial infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnosis of stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Unplanned hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of ventilated children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline in the result of the Endotest® Diagnostic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vp(max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vp(min)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal punch biopsy results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Kujala patellar scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional mobility test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PrEP persistence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Disease control (BPH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: QTc duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in incidence of hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Healing Assessed via MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot Pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Foot Pain and Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Psychosocial functioning changes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of days without invasive ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in variation of pupillary diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in perceived psychosocial well-being - parents
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in perceived psychosocial well-being - children
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in perceived depression from baseline to post-intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline awareness towards substance abuse
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline attitude
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline peer pressure
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change from baseline lifeskills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Composite of all-cause death, stroke, and unplanned hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Duration of Total Parenteral Nutrition (TPN)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change from Baseline in Aberrant Behavior Checklist (ABC) Subscale Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in Vineland Adaptive Behavior Scales-3 (VABS-3) Scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clinical Global Impression Improvement (CGI-I) Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline in Clinical Global Impression Severity (CGI-S) Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to Receipt of 3D Heart Model
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Subjective pain intensity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sacral Slope
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic Incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients maintaining inactive disease or low disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity (mtmDR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity (vtDR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity (mtmDR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity (vtDR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alterations of mRNA levels and splicing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pathological complete response (pCR) at surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in amount of physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Implant Stability as Measured with ISQ values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implant Failure Rate
Endpoint domain: Mortality/survival
Primary endpoint: Injection satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline in Follistatin Serum Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients' and carers' opinions of medication compliance aids
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: reduction in pain intensity during chest physiotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NSAIDs reduce postoperative pain at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: N-terminal pro-B-type natriuretic peptide (NT-pro BNP) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mentalization abilities
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of participants scoring more than 80% on the test of understanding
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Vineland-3 adaptive behavior composite scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sympathetic block level evaluation with skin conductivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sympathetic block level evaluation with skin temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sympathetic block level evaluation by hemodynamic data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the degree of lung severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Physical activity status
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Musculoskeletal Discomfort level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change of Annual healthcare cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of imaging of the Esophagus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Human Brain Receptor Occupancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentration of MIJ821
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: histologic tumor response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: microvascular disease measured by quantitative perfusion on Cardiac MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Parent-Reported Outcome Measurement Information System Depression and Anxiety Short Form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Heel vibration induced reflex latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of iTTP patients achieving clinical remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of iTTP patients experiencing complications during hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Concordance between cytological and flow imaging erythrocyte analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of the developmental quotient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Restorative Quality
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean HbA1c%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean change in HbA1c%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of participants with HbA1c < 7%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to sustained clinical resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of health problems and diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SARS-CoV-2 neutralization antibody levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: muscle strength for scapular muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: muscle ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: muscle angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Accuracy of LAA occluder size selection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceived symptom control
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of difference in fecal microbiota change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Late toxicity of radiotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Dosemetric accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaginal delivery within 24 hours rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Incidence of Ventilation Associated Pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: neuropsychiatric fluctuations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: hallucinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: bradyphrenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: creativity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of patients responding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Subjective Satiety
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 0-45 minutes Glycemic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Emotional Indicators Scale for Children
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Development of clinically relevant visual symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Mean Monthly Migraine Days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in explicit wanting (reward response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Main pathological response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Induction success with low levels of withdrawal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemical pregnancy results
Endpoint domain: Physiological/clinical
Primary endpoint: Pregnancy complications
Endpoint domain: Adverse events/effects
Primary endpoint: AUC-ROC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Unified Parkinson's Disease Rating Scale-III at one day post intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rates of Good Functional Outcomes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Duration of remission (DOR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of days on mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Hours free of events of clinical deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in daily insulin dose requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline in the State-Trait Anxiety Inventory for Children (STAI-C)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in the Children's Depression Inventory-2 (CDI-2)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in the Pediatric Quality of Life Inventory (PedsQL-4.0)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Correct Information Units per Minute
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes following dermatological surgical procedures on the nose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Cataract performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Ammonia as Measured by 24-hour Ammonia (AUC0-24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants Who Have Achieved Complete Response
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: THE/(THF+αTHF) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in depression severity with BLT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment emergent suicidality with BLT
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment emergent mania with BLT
Endpoint domain: Adverse events/effects
Primary endpoint: Oral health literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of Life-Rheumatoid Arthritis
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: FMA lower extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage Time Frozen during turning in place
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to complete Timed Up and Go (TUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pre-surgical anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change of Pain-on-movement (POM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dental anxiety assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing